VivoSim Labs, Inc. Debt Related Commitment Fees and Debt Issuance Costs
VivoSim Labs, Inc. (VIVS) reported Debt Related Commitment Fees and Debt Issuance Costs of $0 for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2015-06-09
- VivoSim Labs, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. debt related commitment fees and debt issuance costs for the quarter ending 2012-03-31 was $2.13M.
- VivoSim Labs, Inc. debt related commitment fees and debt issuance costs for fiscal 2015 was $0.00.
- VivoSim Labs, Inc. debt related commitment fees and debt issuance costs for fiscal 2014 was $0.00.
- VivoSim Labs, Inc. debt related commitment fees and debt issuance costs for fiscal 2012 was $2.13M.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 12 month | Debt Related Commitment Fees and Debt Issuance Costs 83 month |
|---|---|---|---|
| 2015-03-31 | $0.00 10-K · filed 2015-06-09 | ||
| 2014-03-31 | $0.00 10-K · filed 2015-06-09 | $2.13M 10-K · filed 2014-06-10 | |
| 2013-03-31 | $0.00 10-K · filed 2015-06-09 | ||
| 2012-12-31 | $2.13M 10-K · filed 2015-06-09 | ||
| 2012-03-31 | $2.13M 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |